Update on clinical and immunological features of eosinophilic gastrointestinal diseases

Current Opinion in Gastroenterology

Volumn 27, Issue 6, 2011, Pages 515-522

  Masterson, Joanne C ^a   Furuta, Glenn T ^a   Lee, James J ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

eosinophilic esophagitis; eotaxin; filaggrin; mucosa; thymic stromal lymphopoetin

Indexed keywords

CXCL1 CHEMOKINE; EOSINOPHIL PEROXIDASE; EOTAXIN 3; FILAGGRIN; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; MAJOR BASIC PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA1;

EOSINOPHIL; EOSINOPHILIC COLITIS; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTRITIS; EOSINOPHILIC GASTROENTERITIS; EOSINOPHILIC GASTROINTESTINAL DISORDER; HUMAN; MICROENVIRONMENT; NONHUMAN; PATIENT CARE; REVIEW; TH2 CELL;

ENTERITIS; EOSINOPHILIA; EOSINOPHILS; GASTRITIS; HUMANS;

EID: 80054681179     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32834b314c     Document Type: Review

References (75)

1. Collins MH. Histopathology associated with eosinophilic gastrointestinal diseases. Immunol Allergy Clin North Am 2009;29:109-117; x-xi.
2. Spergel JM, Book WM, Mays E, et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr 2011;52:300-306. Multidisciplinary group and advocacy teamed to identify the highly variable pattern of diagnostic approaches of healthcare providers. It emphasizes need for well publicized consensus recommendations.
3. Doyle LA, Odze RD. Eosinophilic esophagitis without abundant eosinophils? The expanding spectrum of a disease that is difficult to define. Dig Dis Sci 2011;56:1923-1925.
4. Foroutan M, Norouzi A, Molaei M, et al. Eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease. Dig Dis Sci 2010;55:28-31.
5. Kanakala V, Lamb CA, Haigh C, et al. The diagnosis of primary eosinophilic oesophagitis in adults: missed or misinterpreted? Eur J Gastroenterol Hepatol 2010;22:848-855.
6. Odze RD. Pathology of eosinophilic esophagitis: what the clinician needs to know. Am J Gastroenterol 2009;104:485-490.
7. Patel N, Busler JF, Geisinger K, Hill I. Are pathologists accurately diagnosing eosinophilic esophagitis in children? A 9-year single academic institutional experience with interobserver observations. Int J Surg Pathol 2011;19:290-296.
8. Lowichik A, Weinberg A. A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Mod Pathol 1996;9:110-114. (Pubitemid 26092098)
9. DeBrosse CW, Case JW, Putnam PE, et al. Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatr Dev Pathol 2006;9:210-218. (Pubitemid 44140386)
10. Kalach N, Huvenne H, Gosset P, et al. Eosinophil counts in upper digestive mucosa of western European children: variations with age, organs, symptoms, Helicobacter pylori status, and pathological findings. J Pediatr Gastroenterol Nutr 2011;52:175-182.
11. Lwin T, Melton SD, Genta RM. Eosinophilic gastritis: histopathological characterization and quantification of the normal gastric eosinophil content. Mod Pathol 2011;24:556-563.
12. Pensabene L, Brundler MA, Bank JM, Di Lorenzo C. Evaluation of mucosal eosinophils in the pediatric colon. Dig Dis Sci 2005;50:221-229. (Pubitemid 40311524)
13. Saad A. Normal quantity and distribution of mast cells and eosinophils in the pediatric colon. Pediatr Dev Pathol 2011. PMID: 21341989.
14. Bonis PA. Putting the puzzle together: epidemiological and clinical clues in the etiology of eosinophilic esophagitis. Immunol Allergy Clin North Am 2009;29:41-52; viii.
15. Kaijser R. To the attention of allergic affections of the digestive tract, from the standpoint of the surgeon. Arch Klin Chir 1937;188:36-64.
16. Klein NC, Hargrove RL, Sleisenger MH, Jeffries GH. Eosinophilic gastroenteritis. Medicine (Baltimore) 1970;49:299-319.
17. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004;113:11-28; quiz 29.
18. Fleischer DM, Atkins D. Evaluation of the patient with suspected eosinophilic gastrointestinal disease. Immunol Allergy Clin North Am 2009;29:53-63; ix.
19. Hurtado CW, Furuta GT, Kramer RE. Etiology of esophageal food impactions in children. J Pediatr Gastroenterol Nutr 2011;52:43-46.
20. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007;133:1342-1363.
21. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011;128:3.e6-20.e6. Multidisciplinary report highlighting newest developments in EoE emphasizing chronicity of disease, variability in phenotypic patterns, and necessity for well designed clinical and translational investigations.
22. Garcia-Compean D, Gonzalez Gonzalez JA, Marrufo Garcia CA, et al. Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: a prospective study. Dig Liver Dis 2011;43:204-208.
23. Hasosah MY, Sukkar GA, Alsahafi AF, et al. Eosinophilic esophagitis in Saudi children: symptoms, histology and endoscopy results. Saudi J Gastroenterol 2011;17:119-123.
24. Abe Y, Iijima K, Ohara S, et al. A Japanese case series of 12 patients with esophageal eosinophilia. J Gastroenterol 2011;46:25-30.
25. Vindigni C, Villanacci V, Marini M, et al. Eosinophilic esophagitis: an Italian experience. Rev Esp Enferm Dig 2010;102:15-19.
26. Aceves SS, Chen D, Newbury RO, et al. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol 2010;126:1198-1204; e1194. First translational study to assess and demonstrate a functional impact in EoE using an ex-vivo system. Mechanistic impact of mast cells in this process is also demonstrated in this article.
27. Basseri B, Levy M, Wang HL, et al. Redefining the role of lymphocytes in gastroesophageal reflux disease and eosinophilic esophagitis. Dis Esophagus 2010;23:368-376.
28. Lee S, de Boer WB, Naran A, et al. More than just counting eosinophils: proximal oesophageal involvement and subepithelial sclerosis are major diagnostic criteria for eosinophilic oesophagitis. J Clin Pathol 2010;63:644-647.
29. Mulder DJ, Justinich CJ. B cells, IgEand mechanisms of type I hypersensitivity in eosinophilic oesophagitis. Gut 2010;59:6-7.
30. Vicario M, Blanchard C, Stringer KF, et al. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 2010;59:12-20.
31. Dellon ES, Chen X, Miller CR, et al. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol 2011;106:264-271. Translational study identifying potential role of tryptase staining as a tool to distiguish between commonly confused diseases.
32. Li-Kim-Moy JP, Tobias V, Day AS, et al. Esophageal subepithelial fibrosis and hyalinization are features of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2011;52:147-153.
33. Kephart GM, Alexander JA, Arora AS, et al. Marked deposition of eosinophilderived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol 2010;105:298-307.
34. Mueller S, Aigner T, Neureiter D, Stolte M. Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. J Clin Pathol 2006;59:1175-1180. (Pubitemid 44787138)
35. Mueller S, Neureiter D, Aigner T, Stolte M. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastrooesophageal reflux disease on oesophageal biopsy material. Histopathology 2008;53:676-684. (Pubitemid 352768719)
36. Protheroe C, Woodruff SA, de Petris G, et al. A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2009;7:749-755; e711.
37. Chang JY, Choung RS, Lee RM, et al. A shift in the clinical spectrum of eosinophilic gastroenteritis toward the mucosal disease type. Clin Gastroenterol Hepatol 2010;8:669-675; quiz e688.
38. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: aclinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990;31:54-58. (Pubitemid 20037980)
39. Dohil R, Newbury R, Fox L, et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010;139:418-429. Clinical study identifying positive impact of novel form of topical steroid in children with EoE.
40. Straumann A, Conus S, Degen L, et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011;9:400.e1-409.e1. First study identifying positive and safe impact of chronic use of topical steroids in adults.
41. Dellon ES, Gibbs WB, Rubinas TC, et al. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc 2010;71:706-712.
42. Hirano I. Dilation in eosinophilic esophagitis: to do or not to do? Gastrointest Endosc 2010;71:713-714.
43. Schoepfer AM, Gonsalves N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol 2010;105:1062-1070.
44. Jung KW, Gundersen N, Kopacova J, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc 2011;73:15-21.
45. Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastrointestinal eosinophils in health and disease. Adv Immunol 2001;78:291-328. (Pubitemid 32567511)
46. Sanderson CJ. Eosinophil differentiation factor (interleukin-5). Immunol Ser 1990;49:231-256.
47. Frick WE, Sedgwick JB, Busse WW. The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am Rev Respir Dis 1989;139:1401-1406. (Pubitemid 19155497)
48. Fukuda T, Dunnette SL, Reed CE, et al. Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am Rev Respir Dis 1985;132:981-985. (Pubitemid 16221385)
49. Bruijnzeel PL, Rihs S, Virchow JC Jr, et al. Early activation or 'priming' of eosinophils in asthma. Schweiz Med Wochenschr 1992;122:298-301.
50. Dri P, Cramer R, Spessotto P, et al. Eosinophil activation on biologic surfaces. Production of O2-in response to physiologic soluble stimuli is differentially modulated by extracellular matrix components and endothelial cells. J Immunol 1991;147:613-620.
51. Tai PC, Spry CJ, Peterson C, et al. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984;309:182-184. (Pubitemid 14142795)
52. Young JD, Peterson CG, Venge P, Cohn ZA. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986;321:613-616. (Pubitemid 16042213)
53. Yousefi S, Gold JA, Andina N, et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 2008;14:949-953.
54. Lee JJ, Jacobsen EA, McGarry MP, et al. Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy 2010;40:563-575.
55. Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009;137:1238-1249.
56. Blanchard C, Stucke EM, Burwinkel K, et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol 2010;184:4033-4041. Identification of novel genes that may participate in the pathogenesis of EoE including filaggrin, a barrier altering gene that is critical in the development of eczema.
57. Caldwell JM, Blanchard C, Collins MH, et al. Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. J Allergy Clin Immunol 2010;125:879-888; e878.
58. Rothenberg ME, Spergel JM, Sherrill JD, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 2010;42:289-291. Identification of gene variant and tissue overexpression of TSLP in children with EoE.
59. Sherrill JD, Gao PS, Stucke EM, et al. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 2010;126:160-165; e163.
60. Tantibhaedhyangkul U, Tatevian N, Gilger MA, et al. Increased esophageal regulatory T cells and eosinophil characteristics in children with eosinophilic esophagitis and gastroesophageal reflux disease. Ann Clin Lab Sci 2009;39:99-107.
61. Fuentebella J, Patel A, Nguyen T, et al. Increased number of regulatory T cells in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2010;51:283-289.
62. Stuck MC, Straumann A, Simon HU. Relative lack of T regulatory cells in adult eosinophilic esophagitis: no normalization after corticosteroid therapy. Allergy 2011;66:705-707.
63. Mulder DJ, Pooni A, Mak N, et al. Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis. Am J Pathol 2011;178:744-753.
64. Hsu Blatman KS, Gonsalves N, Hirano I, Bryce PJ. Expression of mast cell-associated genes is upregulated in adult eosinophilic esophagitis and responds to steroid or dietary therapy. J Allergy Clin Immunol 2011;127:1307e3-1308e3.
65. Huang JJ, Joh JW, Fuentebella J, et al. Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of eosinophilic esophagitis. Allergy Asthma Clin Immunol 2010;6:25.
66. Blanchard C, Stucke EM, Rodriguez-Jimenez B, et al. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol 2011;127:208-217.
67. Zhu X, Wang M, Mavi P, et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology 2010;139:182-193; e187.
68. Zuo L, Fulkerson PC, Finkelman FD, et al. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha2-inhibited pathway. J Immunol 2010;185:660-669.
69. Roman S, Hirano I, Kwiatek MA, et al. Manometric features of eosinophilic esophagitis in esophageal pressure topography. Neurogastroenterol Motil 2011;23:208-214; e111.
70. Waddell A, Ahrens R, Steinbrecher K, et al. Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C (high) CCR2 (+) inflammatory monocyte/macrophage-derived CCL11. J Immunol 2011;186:5993-6003. This study was based on association of the inflammatory bowel diseases susceptibility loci 17q12 with the chemokine, CCL11. Investigators determine the critical role of specific macrophage population, Ly6C (high) CCR2 (+) inflammatory, in the generation of murine colitis, a finding not previously reported.
71. Furuta GT, Nieuwenhuis EE, Karhausen J, et al. Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol 2005;289:G890-897. (Pubitemid 41532582)
72. Forbes E, Murase T, Yang M, et al. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol 2004;172:5664-5675. (Pubitemid 38542070)
73. McNamee EN, Wermers JD, Masterson JC, et al. Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. Inflamm Bowel Dis 2010;16:743-752.
74. Masterson JC, McNamee EN, Jedlicka P, et al. CCR3 antibody blockade attenuates eosinophilic ileitis and associated remodeling. Am J Pathol (in press).
75. Foster B, Foroughi S, Yin Y, Prussin C. Effect of anti-IgE therapy on food allergen specific T cell responses in eosinophil associated gastrointestinal disorders. Clin Mol Allergy 2011;9:7.